Dynavax Technologies Corporation DVAXW Stock
Dynavax Technologies Corporation Price Chart
Dynavax Technologies Corporation DVAXW Financial and Trading Overview
| Dynavax Technologies Corporation stock price | 14.76 USD |
| Previous Close | 14.76 USD |
| Open | 14.75 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 14.76 - 14.76 USD |
| 52 Week Range | 2.74 - 17 USD |
| Volume | 2 USD |
| Avg. Volume | 9.57K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.364495 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DVAXW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 26.170212 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Dynavax Technologies Corporation Stock Price History
| Beta (5Y Monthly) | 1.364495 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 17 USD |
| 52 Week Low | 2.74 USD |
| 50-Day Moving Average | 9.09 USD |
| 200-Day Moving Average | 8.46 USD |
DVAXW Share Statistics
| Avg. Volume (3 month) | 9.57K USD |
| Avg. Daily Volume (10-Days) | 20 USD |
| Shares Outstanding | N/A |
| Float | 111.24M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2020 |
| Most Recent Quarter (mrq) | September 30, 2021 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -14.66% |
| Operating Margin (ttm) | 18.01% |
| Gross Margin | 48.89% |
| EBITDA Margin | 19.67% |
Management Effectiveness
| Return on Assets (ttm) | 4.64% |
| Return on Equity (ttm) | -56.31% |
Income Statement
| Revenue (ttm) | 262.72M USD |
| Revenue Per Share (ttm) | 2.32 USD |
| Quarterly Revenue Growth (yoy) | 698.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | 51.7M USD |
| Net Income Avi to Common (ttm) | -38533000 USD |
| Diluted EPS (ttm) | -0.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 414.16M USD |
| Total Cash Per Share (mrq) | 3.45 USD |
| Total Debt (mrq) | 258.04M USD |
| Total Debt/Equity (mrq) | 381.85 USD |
| Current Ratio (mrq) | 1.612 |
| Book Value Per Share (mrq) | 0.564 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 199.29M USD |
| Levered Free Cash Flow (ttm) | 176.02M USD |
Profile of Dynavax Technologies Corporation
| Country | United States |
| State | CA |
| City | EmeryVille |
| Address | 2100 Powell Street |
| ZIP | 94608 |
| Phone | 510 848 5100 |
| Website | https://www.dynavax.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 245 |
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Q&A For Dynavax Technologies Corporation Stock
What is a current DVAXW stock price?
Dynavax Technologies Corporation DVAXW stock price today per share is 14.76 USD.
How to purchase Dynavax Technologies Corporation stock?
You can buy DVAXW shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dynavax Technologies Corporation?
The stock symbol or ticker of Dynavax Technologies Corporation is DVAXW.
Which industry does the Dynavax Technologies Corporation company belong to?
The Dynavax Technologies Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dynavax Technologies Corporation have in circulation?
The max supply of Dynavax Technologies Corporation shares is 0.
What is Dynavax Technologies Corporation Price to Earnings Ratio (PE Ratio)?
Dynavax Technologies Corporation PE Ratio is 0.00000000 now.
What was Dynavax Technologies Corporation earnings per share over the trailing 12 months (TTM)?
Dynavax Technologies Corporation EPS is 0 USD over the trailing 12 months.
Which sector does the Dynavax Technologies Corporation company belong to?
The Dynavax Technologies Corporation sector is Healthcare.